(9,10-Di(naphthalen-2-yl)anthracen-2-yl)boronic acid, 95%, 5g

MOGUISTEINE, 97%, 500mg

BIS-2-(5-PHENYLACETAMIDO-1,3,4-THIADIAZOL-2-YL)ETHYL SULFIDE, 95%, 250mg

(5-CHLORO-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZIN-6-YL)BORONIC ACID PINACOL ESTER, 95.0%, 250mg

2-((Oxiran-2-ylmethoxy)methyl)furan, 95%, 25g

GlcNPhth[346Ac]beta(1-3)Gal[246Bn]-beta-MP>98.0%(HPLC)(qNMR)1g

(R)-3-((tert-butoxycarbonyl)amino)-3-cyclopropylpropanoic acid, 97%, 250mg

4-Methoxy-3,5-dimethylbenzonitrile, 95.0%, 1g

N,N,N',N'-Tetraacetylethylenediamine>98.0%(GC)100g

4-(Pyridin-4-yl)benzonitrile, 95%, 100mg

2-(2,6-Difluoro-4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 5g

2,3-Dimethoxy-5-methylcyclohexa-2,5-diene-1,4-dione, 95.0%, 25g

3-Bromo-2-chloro-5-methylpyridine, 98.0%, 5g